Request a Demo


Your subscription could not be saved. Please try again.
Your subscription has been successful.

IHRA, developed by Aarca Research, revolutionizes early detection of metabolic conditions such as Type 2 Diabetes, Hypertension, and Dyslipidemia. Using proprietary software and a third-party thermal camera, IHRA provides risk scores that are crucial for early intervention and management."

Key Features:

Non-Invasive Technology

Safe and non-invasive metabolic health risk assessment using thermal imaging.

Rapid Results

Delivers risk scores in real-time, aiding swift decision-making.

Comprehensive Risk Analysis

Assesses multiple conditions simultaneously to provide a holistic view of metabolic health.

Sample report:

Detailed
Patient Review

Our comorbidity report contains a scale of 0-10 that shows severity of the indicators along with conclusions and next steps for each condition. Users can use this report and approach a dietician and/or a medical professional to get detailed prevention and treatment plan. This screening is not a substitute for a regular physical examination by your healthcare provider.

Download sample report

Technical Specifications:

Technology

Utilises medical thermal imaging with advanced data analytics.

Compatibility

Leverages proprietary software and integrates seamlessly into diverse health systems.

Output

Provides detailed reports outlining individual risk scores for targeted conditions.

User Benefits:

Early Detection

Empowers physicians with the information needed to prevent the progression of metabolic diseases.

Patient Convenience

Simplifies the health assessment process, requiring minimal patient preparation and no physical discomfort.

Enhanced Healthcare Delivery

Enables more effective population health management through scalable screenings.

On-site health screening steps

Hover over or click the cards to see the steps in detail.

Step 1

Step 1

(2 mins)

  • Patient is at the screening location.

  • Patient will be asked to sit for 10 minutes if he is sweating, to bring her body temperature to room temperature.

Step 2

(2 mins)

Step 2

(2 mins)

  • Patient completes a web-based questionier with details of their medical and family history and lifestyle information.

Step 3

(1 min)

Step 3

(1 min)

  • Using an FDA Cleared thermal camera, a one-minute thermal video of the patient's face is taken.

  • The thermal video is upload to cloud software.

Step 4

(2 mins)

Step 4

(2 mins)

  • Our proprietary software analyses this thermal video and a report will be generated. It will be emailed to the patient.

  • If requested, the report will also be made available to a medical professional with the patient consent.

Clinical Validation:

IHRA has undergone extensive clinical trials, proving its efficacy and accuracy in early risk assessment. It's recognized by healthcare professionals for its innovative approach to preventive health. Our publications

Customer Testimonials:

We are extending our heartfelt appreciation for your exceptional dedication and success in conducting the IHRA pilot project for non-invasive screening of Type 2 Diabetes, Hypertension, and Dyslipidemia at KEM Hospital. Your hard work has yielded remarkable results and insights, reaffirming our commitment to innovative healthcare solutions.
Your collaborative approach and unwavering focus on improving healthcare are inspiring. This will provide us with the opportunity to build upon the accomplishments of the pilot and continue our pursuit of meaningful advancements in patient care.
Thank you for your valuable contributions.

Dean
Seth GSMC and KEM Hospitals

The method and screening conducted by the Aarca Research team using a thermal camera are unique and we have come across such technology for the first time. The reports and results published by your team is matching with the health condition of the individuals. We also received positive feedback from the team and the individuals who attended this camp and completed the screenings. We are sure all your endeavours in the coming years will lead to demonstrating more of such commendable initiatives.

Commissionerate of Health Services,
NCD cell, Maharashtra State

IHRA is an effective and reliable solution for the early detection of metabolic comorbidities such as Type II Diabetes, Hypertension and Dyslipidemia. IHRA can be used as a screening tool for the early detection of the onset of these conditions and to inform the healthcare personnel for further investigations. IHRA has the potential for widespread improvement in clinical outcomes and for deployment in large public health programs across communities.

Dept of General Medicine,
Kamineni Hospitals

We have done more than 500 people's screening with this product in less than 3 days. It is quick, accurate and innovative. It's a good concept to know the health issues. Encourages our teams to be proactive about their health. Highly recommended.

Head of Human Resources,
Global engineering and technology solutions company

This method is non-invasive and quick. Face scan using the thermal camera is a powerful innovation to conduct health checks. With this proven accuracy and ease of use, we envision this to be used for health checks for our clients.

Vice President of South Zone,
one of Top 5 insurance company in India

IHRA Applications Across Various Settings

Hospitals

Enhances routine screenings and patient monitoring with non-invasive, rapid health risk assessments.

Insurance Companies

Provides accurate health risk data for underwriting and policy customization.

Corporates

Integrates into employee wellness programs to monitor and manage health risks proactively.

Public Health

Enables large-scale screenings to identify and mitigate prevalent health risks in communities.

FAQs:

Visit our FAQ section to learn more about IHRA: FAQs.

Request Demo

Save time, reduce cost, and improve outcomes by
detecting Type 2 Diabetes, Hypertension and Dyslipidemia Early.